Investigating how MIWI2 in lung cells affects the immune response to Influenza A virus
Lung MIWI2 and the host defense against Influenza A virus
This study is looking at a protein called MIWI2 in lung cells to see how it helps protect against the flu virus, and it's for people who are at higher risk of getting really sick from influenza, with hopes of finding new ways to treat and improve their immune response to the virus.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10908609 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of MIWI2, a protein found in certain lung cells, in the body's defense against Influenza A virus. By using specialized mouse models, researchers are examining how the absence of MIWI2 affects the severity of influenza infections. The study aims to uncover new pathways that could be targeted for developing novel antiviral therapies, especially for patients who are at higher risk of severe influenza outcomes. This could lead to better treatment options and improved immune responses against the virus.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at higher risk for severe influenza infections, such as those with compromised immune systems or chronic respiratory conditions.
Not a fit: Patients who are not at risk for severe influenza infections or those who have already been effectively vaccinated may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new antiviral therapies that enhance the immune response to Influenza A virus, potentially reducing the severity of infections in patients.
How similar studies have performed: Other research has shown promising results in understanding immune responses to viral infections, suggesting that this approach could yield valuable insights.
Where this research is happening
Boston, United States
- Boston University Medical Campus — Boston, United States (Active)
Researchers
- Principal investigator: Henao Vasquez, Jhonatan — Boston University Medical Campus
- Study coordinator: Henao Vasquez, Jhonatan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.